• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在坦桑尼亚南部儿童中开展的针对恶性疟原虫疟疾的SPf66疫苗随机试验。

Randomised trial of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

作者信息

Alonzo P L, Smith T, Schellenberg J R, Masanja H, Mwankusye S, Urassa H, Bastos De Azevedo I, Chongela J, Kobero S, Menendez C

机构信息

Ifakara Centre et NIMR Headquarters, National Institute of Medical Research, Tanzanie.

出版信息

Med Trop (Mars). 1995;55(4 Suppl):41-6.

PMID:8649265
Abstract

Malaria, especially that due to Plasmodium falciparum, is one of the most important parasitic disease in man. It causes more than 400 million cases per year and between 1 to 3 million deaths, mainly among young children and pregnant women in sub-Saharan Africa. The current malaria control strategies using rapid diagnosis and treatment as well as methods to reduce the man-vector contact have had limited success. In Kilombero district (Southern Tanzania), malaria transmission is perennial (parasite prevalence > or = 80% all year) and intense (approximatively 300 infectious bites per year). At the household level, each under-5 child suffers on average 3 clinical fever episodes per year. Minimum estimated community rates for serious malaria (cerebral malaria or malaria and anaemia) affect approximatively 5% of all children. Under conditions of a field experiment, the annual incidence of a febrile illness (axillary temperature > or = 37.5 degrees C) reported to the curative primary health services in each child was 0.86 of which 0,35 can be attributed to Plasmodium falciparum malaria. The best estimate of the SPf66 vaccine protective efficacy in the Kilombero was 31% (95% CI : 0.52).

摘要

疟疾,尤其是由恶性疟原虫引起的疟疾,是人类最重要的寄生虫病之一。它每年导致超过4亿例病例,100万至300万人死亡,主要发生在撒哈拉以南非洲的幼儿和孕妇中。目前使用快速诊断和治疗以及减少人与媒介接触的方法的疟疾控制策略取得的成功有限。在基洛梅罗区(坦桑尼亚南部),疟疾传播常年存在(全年寄生虫感染率≥80%)且强度很大(每年约有300次感染性叮咬)。在家庭层面,每个5岁以下儿童平均每年患3次临床发热。严重疟疾(脑型疟疾或疟疾合并贫血)的最低估计社区发病率约影响所有儿童的5%。在一项现场试验条件下,向每个儿童的治疗性初级卫生服务机构报告的发热疾病(腋窝温度≥37.5摄氏度)的年发病率为0.86,其中0.35可归因于恶性疟原虫疟疾。在基洛梅罗,SPf66疫苗保护效力的最佳估计值为31%(95%可信区间:0.52)。

相似文献

1
Randomised trial of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.在坦桑尼亚南部儿童中开展的针对恶性疟原虫疟疾的SPf66疫苗随机试验。
Med Trop (Mars). 1995;55(4 Suppl):41-6.
2
Efficacy trial of malaria vaccine SPf66 in Gambian infants.疟疾疫苗SPf66在冈比亚婴儿中的疗效试验。
Lancet. 1995 Aug 19;346(8973):462-7. doi: 10.1016/s0140-6736(95)91321-1.
3
Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.SPf66疫苗预防坦桑尼亚南部儿童恶性疟原虫疟疾疗效的随机试验。
Lancet. 1994 Oct 29;344(8931):1175-81. doi: 10.1016/s0140-6736(94)90505-3.
4
The development of malaria vaccines: SPf66--what next?疟疾疫苗的发展:SPf66——下一步何去何从?
Schweiz Med Wochenschr. 1996 Jul 9;126(27-28):1210-5.
5
Epidemiological features of severe paediatric malaria in north western Ethiopia.埃塞俄比亚西北部重症儿童疟疾的流行病学特征
East Afr Med J. 1997 Dec;74(12):780-3.
6
Malaria morbidity and immunity among residents of villages with different Plasmodium falciparum transmission intensity in North-Eastern Tanzania.坦桑尼亚东北部不同恶性疟原虫传播强度村庄居民中的疟疾发病率与免疫力
Malar J. 2004 Jul 28;3:26. doi: 10.1186/1475-2875-3-26.
7
Synthetic vaccine update: applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization.合成疫苗进展:借鉴近期SPf66疟疾疫苗理化、结构和免疫学特征研究的经验教训
Vaccine. 2007 May 30;25(22):4487-501. doi: 10.1016/j.vaccine.2007.03.016. Epub 2007 Mar 26.
8
An evaluation of surveillance of malaria at primary health care level in Kenya.肯尼亚初级卫生保健层面疟疾监测评估
East Afr Med J. 1997 Sep;74(9):573-5.
9
Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group.泰国西北部儿童中SPf66疟疾疫苗的随机双盲安慰剂对照试验。索克洛SPf66疟疾疫苗试验组。
Lancet. 1996 Sep 14;348(9029):701-7. doi: 10.1016/s0140-6736(96)04465-0.
10
Prevalence of malaria parasitaemia and associated factors in febrile under-5 children seen in Primary Health Care Centres in Jos, North Central Nigeria.尼日利亚中北部乔斯市初级卫生保健中心就诊的5岁以下发热儿童疟疾寄生虫血症患病率及相关因素
Niger Postgrad Med J. 2008 Jun;15(2):65-9.

引用本文的文献

1
Measures of clinical malaria in field trials of interventions against Plasmodium falciparum.针对恶性疟原虫的干预措施现场试验中的临床疟疾测量方法。
Malar J. 2007 May 2;6:53. doi: 10.1186/1475-2875-6-53.
2
Vaccines for preventing malaria (SPf66).预防疟疾的疫苗(SPf66)
Cochrane Database Syst Rev. 2006 Apr 19;2006(2):CD005966. doi: 10.1002/14651858.CD005966.